Go to the list of all blogs
John Y White's Avatar
published in Blogs
Oct 02, 2026
iShares 20+ Year Treasury Bond ETF (TLT) Draws Steady Inflows Despite Recent Price Pressure

iShares 20+ Year Treasury Bond ETF (TLT) Draws Steady Inflows Despite Recent Price Pressure

Key Takeaways

  • TLT tracks an index of U.S. Treasury bonds with remaining maturities greater than 20 years, giving it one of the longest durations in the fixed-income ETF universe, with an effective duration of roughly 15 years.
  • Long-dated Treasury yields have climbed to multi-decade highs, with the 30-year yield near 5.6% and the 10-year near 5.3%, driving bond prices lower.
  • The fund has fallen roughly 5% over the past month and approximately 9–10% over the past quarter as real yields and the term premium moved higher.
  • Despite the drawdown, investors added more than $2 billion over the past month, underscoring a persistent "buy-the-dip" rate trade into long-duration Treasuries.
  • The portfolio holds roughly 47 Treasury issues, carries an expense ratio of 0.15%, and offers a 30-day SEC yield above 5% alongside monthly distributions.

TLT Structure and Core Holdings

The iShares 20+ Year Treasury Bond ETF is a passively managed fund that seeks to track the ICE U.S. Treasury 20+ Year Bond Index, which measures U.S. Treasury securities with remaining maturities greater than 20 years. Launched in 2002, the fund holds approximately 47 Treasury issues and allocates essentially its entire portfolio — about 99.6% — to U.S. government bonds, with a small cash buffer.

Because TLT concentrates on the longest-dated segment of the yield curve, its price is unusually sensitive to interest-rate changes. Its effective duration of roughly 15 years and average maturity of about 26 years mean that even a modest move in long-dated yields translates into an outsized change in fund price. The largest positions are long-maturity Treasury bonds, including the 2% due 2051, the 1.875% due 2051, and several higher-coupon issues from the 2050s. The fund carries an expense ratio of 0.15% and distributes income monthly.

Market Backdrop for Long-Duration Treasuries

The environment surrounding long-duration Treasuries has turned decidedly challenging. The Federal Reserve has been tightening policy, and markets have repriced the path of interest rates toward "higher for longer." Inflation remains above the Fed's target, with the Personal Consumption Expenditures price index rising about 3.4% year over year and core PCE near 3.0%.

Supply dynamics have added pressure. U.S. federal debt has moved beyond $40 trillion, and heavy government issuance competes with a wave of corporate borrowing as large technology firms fund data-center buildouts. Meanwhile, geopolitical tensions and elevated energy prices have reinforced inflation expectations. The result has been a notable rise in real yields and in the term premium — the extra compensation investors demand to hold long-dated debt rather than rolling short-term securities. I also checked this using Tickeron’s AI Screener to see how TLT compares to other rate-sensitive funds.

Performance Trends and Positioning

TLT has declined roughly 5% over the past month and approximately 9–10% over the past quarter, with the 30-year Treasury yield climbing to levels last seen in the early 2000s and the 10-year yield reaching heights not seen since 2007. The drawdown has been largely trend-driven rather than range-bound, reflecting a steady repricing of long-duration risk rather than a single shock.

Because the fund's holdings are exclusively U.S. Treasuries, its performance is driven almost entirely by the direction of long-dated yields rather than by credit fundamentals or individual issuer news. The rise in real yields — the 30-year real yield moved above 3% — has been the dominant factor, indicating that investors are demanding a higher inflation-adjusted return to lock up capital for decades.

Notably, positioning has been contrarian. Despite the decline, the fund has received substantial inflows, with more than $2 billion added over the past month and several billion over the trailing six months. Assets under management sit above $46 billion. Retail investors in particular have been aggressive buyers, treating elevated yields as an opportunity even as prices fall. TLT has declined roughly 11% year to date in 2026 and trades well below its 2020 peak.

Factors to Watch in 2026

The trajectory of long-dated Treasury yields will remain the single most important driver of TLT in 2026. Investors should monitor the Fed's policy path, incoming inflation data, and the pace of Treasury issuance, all of which influence real yields and the term premium. A sustained cooling in core PCE or a meaningful slowdown in economic growth could ease pressure on long-duration assets, while persistent inflation or further supply expansion could extend the repricing.

Energy prices and geopolitical developments also matter, given their impact on inflation expectations. Capital flows present a two-sided dynamic: heavy dip-buying has provided demand, but concentrated retail positioning can amplify volatility if the trend continues. Finally, competition among long-duration bond ETFs and shifting institutional preferences toward shorter-duration or actively managed strategies may shape fund-level demand. None of these factors constitute a prediction of future price direction, but together they define the structural backdrop most likely to influence the fund in the months ahead.

Refining ETF Research with AI Tools

In my own process, I turn to Tickeron’s AI Screener when I want a systematic way to compare bond ETFs like TLT against peers on technicals, volatility, and flow patterns. The platform scans thousands of securities and surfaces ideas that align with a rate-sensitive strategy, helping me stay efficient without replacing my own judgment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TLT

Contributor

John Y White's AvatarJohn Y White|Beginner

Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active&section=trades&via=john


TLT's Indicator enters downward trend

The Aroon Indicator for TLT entered a downward trend on October 05, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 291 similar instances where the Aroon Indicator formed such a pattern. In 244 of the 291 cases the stock moved lower. This puts the odds of a downward move at 84%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TLT as a result. In 77 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.

The Moving Average Convergence Divergence Histogram (MACD) for TLT turned negative on September 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 36 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TLT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.33% 3-day Advance, the price is estimated to grow further. Considering data from situations where TLT advanced for three days, in 197 of 279 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

TLT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Industry description

The investment seeks to track the investment results of the ICE® U.S. Treasury 20+ Year Bond Index (the "underlying index"). The underlying index consists of publicly-issued U.S. Treasury securities that have a remaining maturity greater than twenty years and have $300 million or more of outstanding face value, excluding amounts held by the Federal Reserve System (the “Fed”). The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in U.S. Treasury securities that manager believes will help the fund track the underlying index.
View a ticker or compare two or three
TLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category LongGovernment

Category
Long Government
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Sable Offshore Corp. (SOC) shares fell 7.40% in the most recent completed session, closing at $16.52 versus a prior close of $17.84. The pullback followed a volatile stretch in which SOC traded between $15.76 and $19.21 over just two sessions, reflecting profit‑taking after a strong run in March.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).